 SOUTH SAN FRANCISCO, Calif BEIJING--BUSINESS WIRE--AcornMed Biotechnology Co., Ltd. AcornMed, a precision medicine organization that specializes in the testing and analysis of solid and blood tumors, announced today that they will incorporate Twist Bioscience next generation sequencing NGS target enrichment and library preparation panels into AcornMeds portfolio of tests designed to provide insight into the genetic predisposition and treatment regimens for patients, providing a more ta 